| |
| |
|
| Insider
Information: |
Kelley Kenneth J |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
179,833 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,040,333 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
179,833 |
|
|
| Total
Value |
$8,040,333 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
4
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 165.2%
|
 -3.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
Director |
2021-04-14 |
179,833 |
2007-03-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-05-25 |
4 |
S |
$10.20 |
$230,945 |
D/D |
(22,500) |
15,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2015-03-05 |
4 |
S |
$15.33 |
$613,380 |
D/D |
(40,000) |
194,876 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2015-06-18 |
4 |
S |
$21.00 |
$420,000 |
D/D |
(20,000) |
198,051 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-11-25 |
4 |
S |
$41.50 |
$401,350 |
D/D |
(9,671) |
276,711 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-11-27 |
4 |
S |
$41.25 |
$412,500 |
D/D |
(10,000) |
266,711 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-12-02 |
4 |
S |
$41.00 |
$1,303,472 |
D/D |
(31,792) |
234,919 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-12-07 |
4 |
S |
$41.00 |
$1,438,526 |
D/D |
(35,086) |
199,833 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-03-14 |
4 |
OE |
$2.05 |
$51,250 |
D/D |
25,000 |
40,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-03-19 |
4 |
OE |
$2.05 |
$51,250 |
D/D |
25,000 |
40,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-03-26 |
4 |
OE |
$2.05 |
$51,250 |
D/D |
25,000 |
40,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-04-02 |
4 |
OE |
$4.10 |
$102,500 |
D/D |
25,000 |
40,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-04-09 |
4 |
OE |
$4.10 |
$102,500 |
D/D |
25,000 |
40,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-04-16 |
4 |
OE |
$4.10 |
$102,500 |
D/D |
25,000 |
40,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-04-23 |
4 |
OE |
$4.10 |
$102,500 |
D/D |
25,000 |
40,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-04-30 |
4 |
OE |
$4.10 |
$102,500 |
D/D |
25,000 |
40,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-05-07 |
4 |
OE |
$4.10 |
$51,250 |
D/D |
12,500 |
27,500 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-05-25 |
4 |
OE |
$2.80 |
$79,250 |
D/D |
22,500 |
37,500 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2015-06-05 |
4 |
OE |
$4.94 |
$49,400 |
D/D |
10,000 |
218,051 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2015-08-28 |
4 |
OE |
$10.37 |
$103,700 |
D/D |
10,000 |
208,051 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2012-05-14 |
4 |
B |
$7.49 |
$149,800 |
D/D |
20,000 |
130,000 |
2.39 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2012-08-27 |
4 |
B |
$5.70 |
$113,974 |
D/D |
20,000 |
150,000 |
2.39 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-03-19 |
4 |
B |
$14.19 |
$748,697 |
D/D |
52,629 |
277,553 |
2.39 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-03-14 |
4 |
AS |
$7.81 |
$198,950 |
D/D |
(25,000) |
15,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-03-19 |
4 |
AS |
$8.56 |
$217,586 |
D/D |
(25,000) |
15,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-03-26 |
4 |
AS |
$8.33 |
$136,657 |
D/D |
(16,262) |
23,738 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
